Targeted therapy may halt breast cancer spreadNovember 6th, 2008 - 4:55 pm ICT by ANI
Washington, Nov 6 (ANI): In a new study, scientists have found that a therapy targeting a protein, called cyclin D1, may block the expansion of breast cancer stem cells.
The study shows how stem cell expansion in breast cancer (called Notch activity) takes place.
Breast cancer stem cells are known to be involved in therapy resistance and the recurrence of cancerous tumours.
Headed by Dr. Richard Pestell and colleagues at Thomas Jefferson University, the study was the first to show that cyclin d1 is required for breast cancer growth in mice.
It is known that cyclin d1 is over-expressed in human breast cancer, thus, the results of the study may explain how cyclin d1 contributes to breast tumour growth, and provide the rationale for targeted therapies at cancerous stem cells in humans.
“Breast and other cancers are maintained through a population of cancer stem cells. By specifically targeting cancer stem cells we hope to reduce recurrence and improve therapy responses,” said Pestell.
Cancer is formed due to the accumulation of multiple genetic lesions that ultimately result in unregulated cell cycle, and Notch activity is a key determinant of the cellular development and differentiation related to this process.
The molecular mechanisms regulating Notch activity are of fundamental importance for future therapy because Notch signalling is activated in human breast cancer, (and a negative regulator of Notch signalling reduces the disease).
The study is appearing in Clinical and Translational Science. (ANI)
- Normal healthy breast cells can help kill cancer cells - Apr 14, 2011
- Key enzyme that controls growth of breast cancer cells identified - Nov 19, 2010
- New way to halt expansion of breast cancer stem cells discovered - Nov 24, 2010
- Personalized cancer medicine now a step closer to reality - Apr 16, 2011
- Mechanism involved in breast cancer's spread to bone uncovered - Feb 04, 2011
- Genetic pathways involved in breast cancer identified - Mar 04, 2011
- 'Longevity' protein may ward off precursor to prostate cancer - Jan 14, 2011
- Overabundance of protein promotes growth of breast cancer stem cells - Feb 16, 2011
- Diabetes drug reduces cancer risk - Nov 27, 2011
- Small molecules 'could block cell proliferation in cancerous human tumor' - Apr 14, 2011
- Potential therapeutic target for brain cancer identified - Feb 23, 2010
- Scientists provide genetic evidence that antioxidants can help treat cancer - Feb 16, 2011
- Enzyme essential for healthy lung development discovered - Mar 30, 2011
- Silencing 'hedgehog' molecule halts cancer - Jun 06, 2011
- Drug used to treat asthma 'prevents spread of breast cancer' - Nov 04, 2010
Tags: breast cancer, cancer growth, cancerous tumours, cell expansion, cellular development, d1, determinant, differentiation, dr richard, fundamental importance, genetic lesions, human breast cancer, molecular mechanisms, negative regulator, pestell, place breast, recurrence, stem cells, thomas jefferson, thomas jefferson university